BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zippi M, Fiorino S, Budriesi R, Micucci M, Corazza I, Pica R, de Biase D, Gallo CG, Hong W. Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis. World J Clin Cases 2021; 9(12): 2763-2777 [PMID: 33969059 DOI: 10.12998/wjcc.v9.i12.2763]
URL: https://www.wjgnet.com/1007-9327/full/v9/i12/2763.htm
Number Citing Articles
T. E. Kugler, I. S. Malovichko, V. B. Gnilitskaya, A. L. Khristulenko, N. F. Yarovaya. Proton Pump Inhibitors in the COVID-19 PandemicThe Russian Archives of Internal Medicine 2022; 12(4): 245 doi: 10.20514/2226-6704-2022-12-4-245-253
Verena Schöning, Felix Hammann. Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 PatientsPharmaceutics 2022; 14(9): 1828 doi: 10.3390/pharmaceutics14091828
M.A. Shokri, T. Moghadam Fard, T. Ramim, A. Hejrati, L. Hejrati, M. Mokhtare. What is the role of proton pump inhibitors consumption on the clinical presentation and severity of COVID-19 infection?Annales Pharmaceutiques Françaises 2022;  doi: 10.1016/j.pharma.2022.08.013
Hong-Bae Kim, Jung-Ha Kim, Bethany J. Wolf. Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysisEuropean Journal of Clinical Pharmacology 2022; 78(3): 383 doi: 10.1007/s00228-021-03255-1